| Large Cell Carcinoma studied in …STUDIED_INderived159 of 159show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079712Phase 2 · active not recruiting Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07278479Phase 1/Phase 2 · recruiting Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235216Phase 2 · recruiting Sacituzumab govitEcan in THYroid Cancers · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07080242Phase 1 · recruiting Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Cervical Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557045Phase 1 · active not recruiting A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902376Phase 1 · recruiting XL092 and Cemiplimab in BRAF WT Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198830Phase 2 · active not recruiting Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485569Phase 1 · active not recruiting Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Skin Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561645Phase 2 · not yet recruiting A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03728361Phase 2 · completed Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453799Phase 2 · suspended Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04675710Phase 2 · active not recruiting Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04171622Phase 2 · active not recruiting Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470489Phase 2 · not yet recruiting Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03181100Phase 2 · active not recruiting Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05652686Phase 1/Phase 2 · recruiting A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049966Phase 1 · completed Atezolizumab in Large Cell Neuroendocrine Carcinoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085056early Phase 1 · active not recruiting Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996249recruiting Prospective Data Collection Initiative on Thoracic Malignancies · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238624Phase 2 · active not recruiting Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Giant Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07068542NA · recruiting Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer · condition mapped PROBABILISTIC · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04010357Phase 2 · completed Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06736418Phase 1 · active not recruiting Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05470595Phase 2 · active not recruiting A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05696548Phase 2 · active not recruiting Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975231Phase 1 · recruiting Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07510594Phase 2 · not yet recruiting A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05680922Phase 1 · active not recruiting DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639191early Phase 1 · recruiting [177Lu]Lu-AKIR001 First-in-human Study · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768178Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05668585Phase 1 · completed A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04458909Phase 3 · terminated Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06374602Phase 2 · recruiting Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07138261not yet recruiting Taiwanese Anaplastic Thyroid Cancer Registry · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400474Phase 2 · completed Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04552769Phase 2 · completed Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06969534Phase 2 · recruiting Safety and Efficacy of Pucotenlimab in pLECC · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579757Phase 1/Phase 2 · terminated Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420754Phase 1 · active not recruiting Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337163completed A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152137Phase 2 · completed Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01956084Phase 1 · completed Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393816Phase 2 · recruiting FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418087Phase 2 · recruiting Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03565536Phase 2 · completed Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06362694Phase 2 · unknown Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731740Phase 2 · withdrawn Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739566Phase 2 · withdrawn Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02244463Phase 1/Phase 2 · completed A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06079333Phase 2 · recruiting NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05102292Phase 1/Phase 2 · unknown The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946712Phase 3 · terminated S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04452292NA · completed Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05819593unknown Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796960unknown European Multicenter Study on Surgical Management of Advanced Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274937Phase 3 · completed Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02404441Phase 1/Phase 2 · completed Phase I/II Study of PDR001 in Patients With Advanced Malignancies · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236547Phase 2 · completed Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535325Phase 1 · completed Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03122496Phase 1 · completed Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688608Phase 2 · completed Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00896181Phase 2 · completed Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03901378Phase 2 · withdrawn Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01774279unknown interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896958unknown The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958372Phase 1 · completed Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614818unknown A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like Carcinoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02709889Phase 1/Phase 2 · terminated Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04574817Phase 2 · unknown Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00603941Phase 1/Phase 2 · terminated A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950365Phase 2 · completed Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02726503Phase 2 · completed Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430166NA · unknown PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like Carcinoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062868Phase 1 · completed LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073398Phase 1/Phase 2 · completed Vaccine Treatment for Advanced Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03211117Phase 2 · completed Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03305133completed Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00625846Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134912Phase 2 · terminated S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441128Phase 1 · terminated -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654238Phase 2 · completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657369Phase 2 · terminated A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02794077Phase 2 · completed Cyclophosphamide for Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02289144Phase 2 · withdrawn Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00568906terminated Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Giant Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123511Phase 2 · completed Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03774862completed Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study · condition mapped ONTOLOGY_EXACT · 159 trials mapped (50 active) | — | — | Colorectal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02151149Phase 4 · completed Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00955305Phase 2 · terminated Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408694Phase 2 · completed Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126568Phase 2 · terminated Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632203Phase 2 · terminated Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01240590Phase 1/Phase 2 · completed A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02755675Phase 2 · unknown uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02943798Phase 2 · unknown Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01317615Phase 4 · completed RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02516774Phase 1 · withdrawn A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454142Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368992Phase 2 · completed S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059967Phase 1 · withdrawn Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049543Phase 3 · completed Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254734NA · terminated Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668823Phase 1 · completed Photodynamic Therapy in Treating Patients With Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101348Phase 1/Phase 2 · completed Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00507429Phase 2/Phase 3 · terminated Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01701349Phase 3 · withdrawn Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369551Phase 1 · terminated Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095693Phase 2 · terminated Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00596830Phase 3 · terminated Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673049Phase 3 · terminated Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002852Phase 3 · completed Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040794Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118183Phase 2 · completed Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155609NA · completed L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089362Phase 1 · completed Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087412Phase 2 · completed S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020709Phase 3 · completed Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021060Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023959Phase 1 · completed Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042835Phase 1 · terminated Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005838Phase 3 · completed Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01637194Phase 1 · completed Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 159 trials mapped (50 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01497041Phase 2 · unknown A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00280852completed Review of Multimodality Management of Anaplastic Thyroid Cancer · condition mapped ALIAS · 159 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |